Sunday 27 September 2020
Home      All news      Contact us      RSS      India
news18 - 2 month ago

Regeneron profit beats, expects early results from COVID-19 trials in September

Regeneron Pharmaceuticals Inc beat secondquarter profit estimates on Wednesday, helped by higher sales of its eczema drug Dupixent and said it expects initial data from ongoing trials of its COVID19 antibody cocktail next month.


Latest News
Hashtags:   

Regeneron

 | 

profit

 | 

beats

 | 

expects

 | 

early

 | 

results

 | 

COVID

 | 

trials

 | 

September

 | 

Sources